A patch test (PT) may be useful in defining true abacavir hypersensitivity syndrome (AHS). Seven previously PT-positive patients remote from the original AHS were shown to have robust 24 h responses, supporting PT durability. HLA-B*5701 was present in all seven PT-positive versus one of 11 controls tolerating abacavir (P < 0.001). Five of seven PT (71%) versus one of 11 controls (9%) (P = 0.005) showed significant abacavir-specific CD8 proliferation, suggesting a direct role for HLA-B*5701-restricted CD8 cells in the pathophysiology of AHS.

Download full-text PDF

Source
http://dx.doi.org/10.1097/01.aids.0000171414.99409.fbDOI Listing

Publication Analysis

Top Keywords

abacavir hypersensitivity
8
versus controls
8
clinical immunogenetic
4
immunogenetic correlates
4
correlates abacavir
4
hypersensitivity patch
4
patch test
4
test defining
4
defining true
4
true abacavir
4

Similar Publications

Evaluation of cephalosporin allergy: Survey of drug allergy experts.

J Allergy Clin Immunol Glob

February 2025

Division of Allergy, Pulmonary, and Critical Care Medicine, Vanderbilt University Medical Center, Nashville, Tenn.

Background: Since the publication of the 2022 Drug Allergy Practice Parameters (DAPP) of the American Academy of Allergy, Asthma & Immunology (AAAAI) and American College of Allergy, Asthma & Immunology (ACAAI), it is unclear the extent to which the simplified and risk-stratified evaluation of cephalosporin allergy has been incorporated into allergy practice.

Objective: We aimed to assess current cephalosporin allergy testing practices using real case examples.

Methods: An 18-question REDCap survey was sent to the 136 members of the Adverse Reactions to Drugs, Biologics and Latex (ARDBL) Committee of the AAAAI between February and April 2023.

View Article and Find Full Text PDF

COVID-19 and severe cutaneous allergic reactions to sulfonamides.

Allergy Asthma Proc

November 2024

From the Section of Allergy, Asthma and Immunology, Department of Medicine, Pennsylvania State College of Medicine, Hershey, Pennsylvania and.

Sulfonamides are associated with severe cutaneous adverse reactions (SCARs). Coronavirus disease 2019 (COVID-19) triggers an immune response, which may increase the likelihood of developing a hypersensitivity reaction. We sought to explore the impact of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection on the probability of developing SCARs and/or erythema multiforme (EM) reactions to sulfonamides.

View Article and Find Full Text PDF

Disclaimer: In an effort to expedite the publication of articles, AJHP is posting manuscripts online as soon as possible after acceptance. Accepted manuscripts have been peer-reviewed and copyedited, but are posted online before technical formatting and author proofing. These manuscripts are not the final version of record and will be replaced with the final article (formatted per AJHP style and proofed by the authors) at a later time.

View Article and Find Full Text PDF
Article Synopsis
  • - We want to highlight the issue of allergies to excipients like carboxymethylcellulose, which are often overlooked in medical diagnoses.
  • - These overlooked allergies can cause serious health problems for patients.
  • - Lack of awareness can lead to unnecessary restrictions on the medication options available to patients.
View Article and Find Full Text PDF
Article Synopsis
  • Stevens-Johnson syndrome and toxic epidermal necrolysis (SJS/TEN) are severe skin reactions to drugs, involving immune system responses from CD8 T cells.
  • Researchers analyzed skin and blister fluid from 15 SJS/TEN patients using various sequencing techniques, revealing 15 distinct cell types and noting active immune responses in affected areas.
  • Key findings indicate that certain T cell receptors and inflammatory markers in skin tissues could be targeted for new treatments, highlighting the role of keratinocytes and T cells in the disease's progression.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!